Gynaec-Oncology

GYN: 02 Correlation between volume of bone marrow irradiated and haematological toxicity in definitive chemoradiotherapy: A prospective study in cervical cancer Febin Antony, C. Jomon Raphael, K. Mathew Varghese, Paul Gopu, K. Venkatesan Department of Radiation Oncology, Amala Institute of Medical S...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cancer research and therapeutics 2018-11, Vol.14 (11), p.853-870
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:GYN: 02 Correlation between volume of bone marrow irradiated and haematological toxicity in definitive chemoradiotherapy: A prospective study in cervical cancer Febin Antony, C. Jomon Raphael, K. Mathew Varghese, Paul Gopu, K. Venkatesan Department of Radiation Oncology, Amala Institute of Medical Sciences, Thrissur, Kerala, India Objectives: Primary objective is to analyze the volume of bone marrow (BM) irradiated and evaluate the haematological toxicity (HT) in cervical cancer patients receiving definitive chemoradiotherapy (CRT). [...]to formulate bone marrow dose volume constrains with the available data. GYN: 04 Observational study of late complications in carcinoma cervix patients treated with curative radiotherapy G. Kiron, Venkatarmana, Krishna Sharan, Anshul Singh Department of Radiotherapy and Oncology, Shirdi Sai Baba Cancer Hospital and Research Centre, KMC, Manipal, Karnataka, India Aims/Objectives: To estimate the proportion and severity of late complications (Proctitis, Cystitis and Vaginal stenosis in carcinoma cervix patients treated with curative radiotherapy and to find relationship between dose received by rectum and bladder to the severity of the toxicity. Materials and Methods: This was a retrospective observational study done in the Department of Radiotherapy and Oncology, Shirdi Sai baba cancer hospital and research Centre, KMC Manipal during October 2015 - June 2017 of Histopathological proven carcinoma cervix patients treated with radical external beam radiotherapy to a dose of 46-50 Gray and HDR brachytherapy with tandem ovoid applicator with point A based planning to a dose of 7-8 Gray per fraction in 3 fractions/2 fractions with or without concurrent cisplatin based chemotherapy who had at least 6 months of follow up are evaluated and data is collected regarding demographic and disease parameters like age, histology, stage at initial presentation, performance status, dosimetry parameters like, ICRU bladder and rectum point dose, late reactions appearing after six months of completion of RT like cystitis, proctitis and vaginal stenosis.
ISSN:0973-1482
1998-4138
DOI:10.4103/0973-1482.246377